🔗 Share this article

Chancellor Reeves has stated she is planning "targeted action to address household expense issues" in the forthcoming Budget.

In comments to the BBC, she emphasized that lowering price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven developed nations this year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could intervene to bring down utility costs, for example by cutting the current 5% rate of value-added tax charged on energy.

Another option is to lower some of the regulatory levies presently added to household expenses.

Fiscal Constraints and Analyst Expectations

The government will obtain the next report from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these measures.

The expectation from the majority of experts is that Reeves will have to introduce tax increases or budget cuts in order to adhere to her self-imposed fiscal targets.

Earlier on the same day, estimates showed there was a £22bn deficit for the Treasury chief to fill, which is at the lower end of expectations.

"It is a collective task between the Bank of England and the government to bear down further on some of the causes of price increases," Reeves told the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest figures from the OBR had not changed her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with increasing international and trade tensions for the Budget revenue measures, probably to be focused on those "most able to pay."

Global Economic Disputes

Addressing apprehensions about the UK's economic relations with China she said: "Our security interests invariably are paramount."

Recent declaration by Chinese authorities to strengthen export controls on critical minerals and other resources that are key for high-technology production led American leader Donald Trump to threaten an additional 100% import tax on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described China's decision "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the American proposal to participate in its battle with China, Reeves said she was "deeply worried" by China's measures and urged the Chinese government "not to put up barriers and limit trade."

She said the action was "damaging for the world economy and causes further obstacles."

"It is my opinion there are fields where we must challenge China, but there are also important opportunities to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also stated she was working with international partners "regarding our own essential resources strategy, so that we are more independent."

Health Service Drug Costs and Investment

Reeves also acknowledged that the price the NHS spends on medicines could rise as a consequence of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or canceling projects in the UK, with some blaming the modest returns they are obtaining.

Last month, the Science Minister said the price the health service pays for medicines would have to go up to prevent companies and drug research funding departing from the United Kingdom.

Reeves stated to media: "It has been observed because of the pricing regime, that drug testing, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"The objective is to ensure that patients receiving treatment from the NHS are able to access the best life-saving treatments in the globe. And so we are examining all of that, and... seeking to secure additional funding into the UK."